NCT07132684 - Comparison of VA and D/IA Induction Regimens in Elderly Fit Acute Myeloid Leukemia Patients | Biotech Hunter

Enrollment

240

Participants

Timeline

Start Date

August 31, 2025

Primary Completion Date

August 30, 2027

Study Completion Date

August 30, 2028

Conditions

AML, Adult

Interventions

DRUG

Daunorubicin/Idarubicin

Daunorubicin/Idarubicin is used in Induction Therapy and Maintenance Therapy.

DRUG

Cytarabine

Cytarabine is used in Induction Therapy, Consolidation Therapy and Maintenance Therapy.

DRUG

Azacitidine

Azacitidine is used in VA regimen

DRUG

Venetoclax

Venetoclax is used in VA regimen

Trial Locations (1)

RECRUITING

Blood Diseases Hospital, Tianjin

All Listed Sponsors

lead

Institute of Hematology & Blood Diseases Hospital, China

OTHER